The story is all too familiar: promising effects are shown in animal models of Alzheimer’s disease – providing hope for patients, physicians, and researchers alike – only to move on to clinical trials and fail to show any beneficial effects in humans. The drugs intepirdine and solanezumab are recent…
Alzheimer’s disease (AD), is a chronic neural disease which slowly degrades the nervous system. Millions of people worldwide are affected by this disease, in particular those 65 and older. The disease may start a decade before the signs are evident, with a display of early symptoms such as difficulty in…
